Health Catalyst, Inc. (HCAT) Q3 2025 Earnings Call Transcript

Health Catalyst (HCAT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Health Catalyst (HCAT) Q3 Earnings and Revenues Top Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of +20.00% and +1.66%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of +33.33% and +0.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst shareholders approve all proposals at annual meeting By Investing.com

Health Catalyst shareholders approve all proposals at annual meeting

Health Catalyst (HCAT) Upgraded to Buy: Heres Why

Health Catalyst (HCAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.

Health Catalyst (NASDAQ:HCAT) shareholders have endured a 88% loss from investing in the stock five years ago

Long term investing works well, but it doesnt always work for each individual stock. We really hate to see fellow...

Pure Storage, Health Catalyst, AMD, Micron, and FormFactor Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the morning session after President Trump clarified that he had no intention of removing Federal Reserve Chair Jerome Powell, a statement that helped calm markets. Earlier remarks had sparked fears of political interference in decision making at the central bank. With Trump walking back his earlier commen...

Pure Storage, Health Catalyst, AMD, Micron, and FormFactor Stocks Trade Up, What You Need To Know

A number of stocks jumped in the morning session after President Trump clarified that he had no intention of removing Federal Reserve Chair Jerome Powell, a statement that helped calm markets. Earlier remarks had sparked fears of political interference in decision making at the central bank. With Trump walking back his earlier comments, investors likely felt more assured that monetary policy decisions would continue to be guided by data, not drama. That kept the Feds word credible, and more imp

Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025

AI-driven healthcare companies like Butterfly Network and Health Catalyst have all the qualities to emerge as the next big players.

Is the Options Market Predicting a Spike in Health Catalyst (HCAT) Stock?

Investors need to pay close attention to Health Catalyst (HCAT) stock based on the movements in the options market lately.

Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript

Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of -63.64% and 0.28%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst, Inc. (HCAT) Q3 2024 Earnings Call Transcript

Health Catalyst to Announce Third Quarter 2024 Operating Results and Host Conference Call on Wednesday, November 6, 2024

SALT LAKE CITY, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2024 operating results on Wednesday, November 6, 2024, after market close. In conjunction, the company will host a conference call to review the results at 4:30 pm ET on the same day.

Health Catalyst, Inc. (HCAT) Q2 2024 Earnings Call Transcript

Health Catalyst Reports Second Quarter 2024 Results

SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2024.

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include AMC Entertainment (AMC), Exagen (XGN), Health Catalyst (HCAT), CLEAR Secure (YOU) and Applied DNA Sciences (APDN).

Zacks Industry Outlook Highlights Hims & Hers Health, Enovis Corp and Health Catalyst

Hims & Hers Health, Enovis Corp and Health Catalyst are part of the Zacks Industry Outlook article.

3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare

Zacks Medical Info Systems industry stocks like Hims & Hers Health (HIMS), Enovis Corporation (ENOV) and Health Catalyst (HCAT) are expected to gain from the GenAI wave.

Health Catalyst, Inc. (HCAT) Q1 2024 Earnings Call Transcript

3 Medical Info Systems Stocks to Buy as Industry Improves

A few Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Talkspace (TALK) and Health Catalyst (HCAT) are expected to gain from the new normal trends.

Health Catalyst exec sells over $15k in company stock By Investing.com

Health Catalyst exec sells over $15k in company stock